Search results
Showing 31 to 45 of 280 results for coronavirus
people with cancer and COVID-19: Are people who have had SACT recently (that is, within the 4 weeks preceding a diagnosis...
This guideline covers assessment of people aged 16 and over with symptoms and signs of acute respiratory infection (bacterial or viral) at first remote or in-person contact with NHS services. It also covers the initial management of any infections. It aims to support healthcare practitioners in making sure that people’s treatment follows the best care pathway. It forms part of a suite of work on virtual wards being undertaken by NICE.
This quality standard covers the routine antenatal care that women and their babies should receive during pregnancy. It describes high-quality care in priority areas for improvement.
View quality statements for QS22Show all sections
Sections for QS22
- Quality statements
- Quality statement 1: Access to antenatal care
- Quality statement 2: Risk assessment
- Quality statement 3: Continuity of carer
- Quality statement 4: Vaccination
- Quality statement 5: Referral for stop-smoking support and treatment
- Quality statement 6: Healthy eating in pregnancy
- Update information
What is the efficacy and safety of remdesivir for people who have been vaccinated against COVID-19?
against COVID-19? Any explanatory notes(if applicable) Suggested PICO (Population, Intervention, Comparator, Outcomes) P:...
Evidence-based recommendations on talquetamab (Talvey) for treating relapsed and refractory multiple myeloma after 3 or more treatments in adults.
What is the clinical effectiveness and safety of vitamin D for treating COVID-19 in children, young people and adults? Any...
School-based interventions: physical and mental health and wellbeing promotion
In development Reference number: GID-QS10070 Expected publication date: TBC
What is the clinical and cost effectiveness of budesonide for treating COVID-19 in the community in adults, young people...
What are the possible outcomes for people who are critically ill and have COVID-19-associated pulmonary aspergillosis...
(VTE) prophylaxis for people who have been discharged after treatment for COVID-19? Any explanatory notes(if applicable)...
In development Reference number: GID-TA10664 Expected publication date: TBC
Evidence-based recommendations on lenalidomide (Revlimid) for maintenance treatment after an autologous stem cell transplant for newly diagnosed multiple myeloma in adults.
combination of casirivimab and imdevimab at doses other than 8 g for treating COVID-19? Any explanatory notes(if...
to specialist palliative care services improve outcomes for adults with COVID-19 thought to be approaching the end of their...